Assessment of Healing and Function After Bone Sarcoma Reconstruction Surgery
This study is looking at how well bone heals and how much function returns in people who have had reconstructive surgery for bone sarcomas (cancers of the bone), including osteosarcoma, chondrosarcoma, and Ewing's sarcoma. Researchers will observe participants who have had reconstruction with bone grafts or artificial devices, or tumor surgery with regenerative osseous (bone) surgery. They will measure your recovery level at 1 year and 3 years after surgery using questionnaires and physical tests like the Timed Get Up and Go Test. This study is for patients of all ages (4 years and older) who have undergone reconstructive surgery for bone tumors at MSK and have a confirmed diagnosis.
- Study design
- This is an observational study planning to include 300 participants. It will involve assessments over a 3-year period after surgery.
- What's involved
- You would complete questionnaires like the Toronto Extremity Salvage Score and Musculoskeletal Tumor Society Score, and participate in physical tests such as the Timed Get Up and Go Test. You would also have X-rays (Orthogonal Radiographs) and weight-bearing assessments for lower extremities.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for 3 years after their surgery, with assessments at 1 year and 3 years.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas
At a glance
Conditions
Where it's being run
5 sites across 2 statesStudy leadership
- Daniel Prince, MD · PRINCIPAL_INVESTIGATOR · Memorial Sloan Kettering Cancer Center
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Early recovery level1 year from surgery
The primary objective is to assess early recovery level of function of all participants undergoing reconstructive surgery after resection of osseous neoplasms. The early time frame is considered at one year from the neoplasm resection surgery.
- Mid-recovery level3 years from surgery
The primary objective is to assess mid-recovery level of function of all participants undergoing reconstructive surgery after resection of osseous neoplasms. The mid-recovery time frame is considered at one year from the neoplasm resection surgery.